Enzyme replacement therapy with laronidase (Aldurazyme) for treating mucopolysaccharidosis type I
about
Enzymes approved for human therapy: indications, mechanisms and adverse effects.Alternative laronidase dose regimen for patients with mucopolysaccharidosis I: a multinational, retrospective, chart review case series.Characterization of knee alignment in children with mucopolysaccharidosis types I and II and outcome of treatment with guided growth.
P2860
Enzyme replacement therapy with laronidase (Aldurazyme) for treating mucopolysaccharidosis type I
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Enzyme replacement therapy wit ...... g mucopolysaccharidosis type I
@ast
Enzyme replacement therapy wit ...... g mucopolysaccharidosis type I
@en
Enzyme replacement therapy wit ...... g mucopolysaccharidosis type I
@en-gb
Enzyme replacement therapy wit ...... g mucopolysaccharidosis type I
@nl
type
label
Enzyme replacement therapy wit ...... g mucopolysaccharidosis type I
@ast
Enzyme replacement therapy wit ...... g mucopolysaccharidosis type I
@en
Enzyme replacement therapy wit ...... g mucopolysaccharidosis type I
@en-gb
Enzyme replacement therapy wit ...... g mucopolysaccharidosis type I
@nl
prefLabel
Enzyme replacement therapy wit ...... g mucopolysaccharidosis type I
@ast
Enzyme replacement therapy wit ...... g mucopolysaccharidosis type I
@en
Enzyme replacement therapy wit ...... g mucopolysaccharidosis type I
@en-gb
Enzyme replacement therapy wit ...... g mucopolysaccharidosis type I
@nl
P2093
P2860
P3181
P1476
Enzyme replacement therapy wit ...... g mucopolysaccharidosis type I
@en
P2093
Elisabeth Jameson
James E Wraith
Simon Jones
P2860
P3181
P356
10.1002/14651858.CD009354.PUB2
P577
2013-09-26T00:00:00Z